2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gong, R. Articles by Dworkin, L. D. Search for Related Content PubMed PubMed Citation Articles by Gong, R. Articles by Dworkin, L. D.

Hepatocyte Growth Factor Modulates Matrix Metalloproteinases and Plasminogen Activator/Plasmin Proteolytic Pathways in Progressive Renal Interstitial Fibrosis

Rujun Gong^*, Abdalla Rifai, Evelyn M. Tolbert^*, Jason N. Centracchio^* and Lance D. Dworkin^*

*Division of Renal Diseases, Department of Medicine, and Department of Pathology, Rhode Island Hospital, Brown University School of Medicine, Providence, Rhode Island

Correspondence to Dr. Lance D. Dworkin, Division of Renal Diseases, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903; Phone: 401-444-6843; Fax: 401-444-6849; E-mail: LDworkin{at}lifespan.org

ABSTRACT. Evidence suggests that hepatocyte growth factor (HGF) ameliorates renal fibrosis in animal models of chronic renal disease by promoting extracellular matrix catabolism. This study examined the molecular mechanisms of HGF-induced alterations in matrix degradation both in vitro and in vivo. In vitro, HGF increased the collagen catabolizing activity of human proximal tubular epithelial cells (HKC) that were treated with TGF-1. Increased collagen catabolism was associated with enhanced activity of both matrix metalloproteinases (MMP) and plasminogen activators (PA)/plasmin proteolytic pathways. HGF abrogated TGF-1–induced production of the profibrotic tissue inhibitor of metalloproteinase-2 (TIMP-2) and plasminogen activator inhibitor-1 (PAI-1). In addition, HGF induced the production of MMP-9. In vivo, continuous infusion of HGF in the rat remnant kidney model ameliorated renal fibrosis and tubulointerstitial collagen deposition. This was associated with increased tubular expression of MMP-9, enhanced in situ gelatinolytic activity, partially restored plasmin activity and decreased expression of TIMP-2 and PAI-1 in tubular cells, and upregulation of renal TIMP-3 expression. Conversely, blocking of endogenous HGF by an anti-HGF neutralizing antibody increased renal fibrosis and interstitial collagen. This was accompanied by decreased tubular expression of MMP-9, less in situ proteolytic activity, and elevated expression of TIMP-2 and PAI-1 in tubular cells. Collectively, these findings demonstrate that HGF ameliorates renal fibrosis by enhancing extracellular matrix catabolism via both MMP and the PA/plasmin proteolytic pathways.

This article has been cited by other articles:

				R. Gong, A. Rifai, Y. Ge, S. Chen, and L. D. Dworkin Hepatocyte Growth Factor Suppresses Proinflammatory NF{kappa}B Activation through GSK3{beta} Inactivation in Renal Tubular Epithelial Cells J. Biol. Chem., March 21, 2008; 283(12): 7401 - 7410. [Abstract] [Full Text] [PDF]

				L. Jensen, B. Sloth, I. Krog-Mikkelsen, A. Flint, A. Raben, T. Tholstrup, N. Brunner, and A. Astrup A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women Am. J. Clinical Nutrition, January 1, 2008; 87(1): 97 - 105. [Abstract] [Full Text] [PDF]

				C. Yu, R. Gong, A. Rifai, E. M. Tolbert, and L. D. Dworkin Long-Term, High-Dosage Candesartan Suppresses Inflammation and Injury in Chronic Kidney Disease: Nonhemodynamic Renal Protection J. Am. Soc. Nephrol., March 1, 2007; 18(3): 750 - 759. [Abstract] [Full Text] [PDF]

				R. Gong, A. Rifai, and L. D. Dworkin Anti-Inflammatory Effect of Hepatocyte Growth Factor in Chronic Kidney Disease: Targeting the Inflamed Vascular Endothelium J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2464 - 2473. [Abstract] [Full Text] [PDF]

				W. Han, M. K. H. Yap, J. Wang, and S. P. Yip Family-Based Association Analysis of Hepatocyte Growth Factor (HGF) Gene Polymorphisms in High Myopia. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2291 - 2299. [Abstract] [Full Text] [PDF]

				C. Chatziantoniou and J.-C. Dussaule Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Am J Physiol Renal Physiol, August 1, 2005; 289(2): F227 - F234. [Abstract] [Full Text] [PDF]

				P. Biswas, A. Roy, R. Gong, A. Yango, E. Tolbert, J. Centracchio, and L. D. Dworkin Hepatocyte growth factor induces an endothelin-mediated decline in glomerular filtration rate Am J Physiol Renal Physiol, January 1, 2005; 288(1): F8 - F15. [Abstract] [Full Text] [PDF]

				T. Oda, K. Yamakami, F. Omasu, S. Suzuki, S. Miura, T. Sugisaki, and N. Yoshizawa Glomerular Plasmin-Like Activity in Relation to Nephritis-Associated Plasmin Receptor in Acute Poststreptococcal Glomerulonephritis J. Am. Soc. Nephrol., January 1, 2005; 16(1): 247 - 254. [Abstract] [Full Text] [PDF]

				R. Gong, A. Rifai, E. M. Tolbert, P. Biswas, J. N. Centracchio, and L. D. Dworkin Hepatocyte Growth Factor Ameliorates Renal Interstitial Inflammation in Rat Remnant Kidney by Modulating Tubular Expression of Macrophage Chemoattractant Protein-1 and RANTES J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2868 - 2881. [Abstract] [Full Text] [PDF]

				Y. Liu Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action Am J Physiol Renal Physiol, July 1, 2004; 287(1): F7 - F16. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673